# Jim Boyle

> Jim Boyle is Medline’s chief executive officer and a director, roles he has held since 2023. He joined the company as a San Antonio sales representative in 1996, progressed through sales and management positions, and became executive vice president in 2018. A Texas A&M industrial distribution graduate, he became Medline’s first non-family CEO and led the business through its December 2025 Nasdaq listing.

- **Role:** Chief Executive Officer and Director at Medline Inc.
- **Organizations:** Medline Inc., Medline Industries, LP
- **Education:** Bachelor of Science in Industrial Distribution, Texas A&M University
- **Known for:** Became Medline’s first non-family chief executive in 2023., Led Medline through its December 2025 public-market debut., Included in Modern Healthcare’s 100 Most Influential People in Healthcare in 2024 and 2025; ranked No. 27 in 2025.

## Career timeline

- **1996** — Joined Medline as a sales representative in San Antonio, Texas.
- **1996-2014** — Held sales roles including sales trainer, senior account manager and division vice president; individual appointment dates are not specified.
- **2014-2018** — Senior Vice President, Sales, according to Medline’s 2026 proxy statement.
- **2018** — Senior Vice President, National Field Sales, before promotion to executive vice president.
- **2018-2023** — Executive Vice President, Sales, with responsibilities including commercial functions, operations and logistics.
- **2023-10-01** — Became CEO following a five-year succession process; also joined the board in 2023.
- **2025-12** — Led Medline as it began trading on Nasdaq under MDLN.

## Achievements

- Became Medline’s first non-family chief executive in 2023.
- Led Medline through its December 2025 public-market debut.
- Included in Modern Healthcare’s 100 Most Influential People in Healthcare in 2024 and 2025; ranked No. 27 in 2025.
- Medline’s executive biography credits his earlier senior sales leadership tenure with more than doubling annual sales and a 13.2% combined annual growth rate.

## Latest updates

- **2026-10** — Medline announced on October 6 that third-quarter results are scheduled for November 4, 2026.
- **2026-09** — Medline announced Boyle and CFO Mike Drazin as scheduled presenters at the Morgan Stanley conference; its events page lists September 15.
- **2026-08** — Boyle discussed growth and the response to the Tracy distribution-center fire in Medline’s August 5 results announcement. Second-quarter net sales were $7.7 billion, up 11.6%; net income was $139 million, down 58.3%.

## Links

- Website: https://www.medline.com/about-us/who-we-are/jim-boyle/
- LinkedIn: https://www.linkedin.com/in/jim-boyle-a0ab1688

---

Profile page: https://yespress.io/jim-boyle
Published by YesPress — https://yespress.io
Last updated: 2026-10-21